|
Efficacy and safety of abiraterone acetate plus prednisone and androgen deprivation therapy +/- docetaxel in older patients (≥70 years), with de novo metastatic-castration sensitive prostate cancer, compared to younger patients (<70 years): The PEACE-1 trial. |
|
|
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; Pfizer; Sanofi |
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; BMS; Ipsen; janssen; Pfizer; Sanofi |
|
|
Travel, Accommodations, Expenses - Ipsen; Janssen; Pfizer |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Clovis Oncology; Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi |
Speakers' Bureau - MSD Oncology |
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Ipsen; Janssen-Cilag; Pfizer; Roche |
|
|
Employment - Astellas Pharma; AstraZeneca; Bayer; Ferring; Ipsen; Janssen; Takeda |
Speakers' Bureau - Gerson Lehrman Group |
Research Funding - Astellas Medivation (Inst); Janssen (Inst) |
Travel, Accommodations, Expenses - Ipsen |
Other Relationship - Astellas Pharma; Janssen Oncology |
|
|
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Myovant Sciences; Pfizer; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Janssen; Myovant Sciences; Pfizer/Astellas; Sanofi; Steba Biotech; Takeda |
Speakers' Bureau - Amgen; Astellas Pharma; Astellas Pharma; Janssen |
Research Funding - Ferring (Inst) |
Expert Testimony - Steba Biotech |
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Sanofi |
|
|
Honoraria - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; Ipsen; Janssen-Cilag; MSD Oncology; PFIZER; Roche/Genentech; Sanofi/Aventis |
Travel, Accommodations, Expenses - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; IPSEN; Janssen-Cilag; MSD Oncology; Pfizer; Roche/Genentech; Sanofi/Aventis |
|
|
Consulting or Advisory Role - Astellas Oncology; Bristol-Myers Squibb; Janssen; Novartis |
Travel, Accommodations, Expenses - Astellas Oncology; Janssen |
|
|
No Relationships to Disclose |
|
|
Employment - Amethyst Radiotherapy Group BV |
Leadership - Medical Director |
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; Janssen; Sanofi |
Speakers' Bureau - Astellas Oncology; AstraZeneca; Janssen; Sanofi |
Research Funding - Astellas Oncology; AstraZeneca; Janssen; Nanobiotix |
Expert Testimony - Astellas Oncology; Janssen |
Travel, Accommodations, Expenses - Janssen |
|
|
Consulting or Advisory Role - Astellas Pharma; Janssen-Cilag |
Travel, Accommodations, Expenses - Pfizer |
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Meyers-Squibb; Ipsen; MSD Oncology; Pfizer |
Speakers' Bureau - Bristol-Myers-Squibb |
|
|
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); BMS (Inst); IPSEN (Inst); Janssen (Inst); Merck/Pfizer (Inst); MSD Oncology (Inst); Pfizer (Inst); Sanofi/Aventis (Inst) |
Speakers' Bureau - Amgen (Inst); Astellas Pharma (Inst); BMS (Inst); Ipsen (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Sanofi/Aventis (Inst) |
Research Funding - BMS (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Pfizer; Sanofi |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst) |
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer; Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); ESSA (Inst); Janssen Oncology (Inst); Novartis (Inst); Orion; Pfizer (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Janssen; MSD |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Astellas Pharma; AstraZéneca; Bayer; Bristol-Myers Squibb; Johnson & Johnson/Janssen; MSD Oncology; Pfizer; Roche; Sanofi |
Speakers' Bureau - Astellas Pharma; Bayer; Johnson & Johnson |
Research Funding - AB Science (Inst); Aragon Pharmaceuticals (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Blueprint Medicines (Inst); BN ImmunoTherapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb International Corporation (BMS) (Inst); Clovis Oncology (Inst); Cougar Biotechnology (Inst); Deciphera; Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen-Cilag International NV (Inst); Karyopharm Therapeutics (Inst); Laboratories Leurquin Mediolanum (Inst); Lilly (Inst); Medimmune (Inst); Millenium Pharamceuticals (Inst); Nanobiotix (Inst); Novartis Farmacéutica SA (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Sanofi Aventis GmbH (Inst); SFJ Pharmaceuticals Group (Inst); Teva (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; BMS; Ipsen; Roche |